Robert Dean Prentiss
Plus aucun poste en cours
Provenance du réseau au premier degré de Robert Dean Prentiss
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 17 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robert Dean Prentiss via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Executive Officer Director/Board Member Human Resources Officer | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer General Counsel Chief Tech/Sci/R&D Officer | |
| TRANSLATE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Analyst-Equity Analyst-Equity | |
| FUSN PHAR | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer Chief Tech/Sci/R&D Officer | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member President | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Chairman Founder | |
| Providence College | College/University | Masters Business Admin Undergraduate Degree | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| St. Joseph's University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin | |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO | |
| Suffolk University | College/University | Undergraduate Degree | |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Breakaway Technologies, Inc.
 Breakaway Technologies, Inc. Packaged SoftwareTechnology Services Breakaway Technologies, Inc. develops analytic and business intelligence software. The private company is based in Yardley, PA. The company was founded by Darby Williams. | Packaged Software | Director of Finance/CFO | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| Financial Executives International Philadelphia Chapter | Director/Board Member | ||
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact | |
Vicarius Pharma AG
 Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
| University of Birmingham | College/University | Doctorate Degree | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| ELANCO ANIMAL HEALTH INCORPORATED | Biotechnology | Director/Board Member | |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Part of Mereo BioPharma Group Plc, Mereo Biopharma 3 Ltd. develops bio pharm products. The company is based in London, UK. | Biotechnology | Director/Board Member | |
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 2 Ltd. is a British company that provides research and experimental development for biotechnology. The company is based in London, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member | |
Nomura International Plc
 Nomura International Plc Investment Banks/BrokersFinance Nomura International Plc provides a variety of financial services including advisement, investment banking and asset management. It trades in and sells fixed income and equity products, including related derivatives; and provides investment banking services, and corporate finance and private equity services. The company is also involved in asset and principal finance business. It offers investment advisory and management, custody, and employment services. Nomura International was founded in 1981 and is headquartered in London, the United Kingdom. | Investment Banks/Brokers | Corporate Officer/Principal | |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| Yale University | College/University | Doctorate Degree | |
| Trinity University | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 32 |
| Royaume-Uni | 11 |
| Canada | 4 |
| Autriche | 2 |
| France | 2 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 3 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 90 |
| Independent Dir/Board Member | 44 |
| Corporate Officer/Principal | 41 |
| Director of Finance/CFO | 29 |
| Chairman | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michael Wyzga | 31 |
| Charles Rowland | 25 |
| Ronald Renaud | 24 |
| Anthony Adam Rosenberg | 23 |
| Denise Scots-Knight | 20 |
| Robert E. Pelzer | 12 |
| Brian Goff | 11 |
| Tom R. Hodgson | 10 |
| Daniella Beckman | 10 |
| Eric S. Hoffman | 8 |
| Maria D. Stahl | 8 |
| W. Roger Rush | 8 |
| Charles W. Cramb | 7 |
| Paul J. Fanning | 7 |
| Keith Pietropaolo | 6 |
- Bourse
- Insiders
- Robert Dean Prentiss
- Connexions Sociétés
